Abstract
A considerable variability in the incidence and prevalence of diabetic nephropathy (DN) coheres with an important contribution of multigenetic predisposition in the development of DN. Some genes, which probably participate in the pathogenesis of diabetic nephropathy, also play a role in the regulation of blood pressure, familial hyperlipidemia, familial hypertension and other diseases of the cardiovascular system. We have examined the association of diabetic nephropathy, nephropathy of non-diabetic origin, hypertension and of type 2 diabetes itself with several genetic polymorphisms (the insertion/deletion polymorphism in the gene for angiotensin-converting enzyme, the G/T polymorphism in the glucose transporter 1 gene, the G/T (894) polymorphism and the T/C (−786) polymorphism in the eNOS gene in three groups of patients with diabetes mellitus: 1) patients without diabetic nephropathy (DM); 2) patients with DN; 3) patients with nephropathy of non-diabetic origin (NDRD). Angiotensin-converting enzyme is an important factor in a development of arterial hypertension, but in our groups of Central European diabetic patients the I/D polymorphism was not associated with diabetic nephropathy. Furthermore, we have confirmed that the T/C (T786C) polymorphism in the eNOS gene is associated with metabolic syndrome including type 2 diabetes.
[1] Imperatore G., Knowler W.C., Nelson R.G., Hanson R.L., Genetics of diabetic nephropathy in the pima Indians, Current Diabetes Reports, 2001, 1, 275–281 http://dx.doi.org/10.1007/s11892-001-0046-210.1007/s11892-001-0046-2Search in Google Scholar
[2] Miyata T., Novel mechanisms and therapeutic options in diabetic nephropathy, Pol. Arch. Med. Wewn, 2009, 119, 261–264 10.20452/pamw.676Search in Google Scholar
[3] Maeda Y., Shiigai T., Diet therapy in diabetic nephropathy, Contrib. Nephrol., 2007, 155, 50–58 http://dx.doi.org/10.1159/00010099610.1159/000100996Search in Google Scholar
[4] Pettitt D.J., Forman M.R., Hanson R.L., Knowler W.C., Bennett P.H., Breastfeeding and incidence of non-insulin-dependent diabetes mellitus in Pima Indians, Lancet, 1997, 350, 166–168 http://dx.doi.org/10.1016/S0140-6736(96)12103-610.1016/S0140-6736(96)12103-6Search in Google Scholar
[5] Freedman B.I., Bowden D.W., The role of genetic factors in the development of end-stage renal disease, Curr. Opin. Nephrol. Hypertens., 1995, 4, 230–234 http://dx.doi.org/10.1097/00041552-199505000-0000510.1097/00041552-199505000-00005Search in Google Scholar
[6] Quinn M., Angelico M.C., Warram J.H., Krolewski A.S., Familial factors determine the development of diabetic nephropathy in patients with IDDM, Diabetologia, 1996, 39, 940–945 http://dx.doi.org/10.1007/BF0040391310.1007/BF00403913Search in Google Scholar
[7] Schmidt S., Ritz E., Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes, Nephrol. Dial. Transplant., 1997, 12,Suppl.2, 37–41 Search in Google Scholar
[8] Rigat C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F., An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels, J. Clin. Invest., 1990, 86, 1343–1346 http://dx.doi.org/10.1172/JCI11484410.1172/JCI114844Search in Google Scholar
[9] Harden P.N., Geddes C., Rowe P.A., McIlroy J.H., Boulton-Jones M., Rodger R.S., et al., Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy, Lancet, 1995, 345, 1540–1542 http://dx.doi.org/10.1016/S0140-6736(95)91088-310.1016/S0140-6736(95)91088-3Search in Google Scholar
[10] Niu T., Xu X., Rogus J., Zhou Y., Chen C., Yang J., et al., Angiotensinogen gene and hypertension in Chinese, J. Clin. Invest., 1998, 101, 188–194 http://dx.doi.org/10.1172/JCI11987610.1172/JCI119876Search in Google Scholar PubMed PubMed Central
[11] Hodgkinson A.D., Page T., Millward B.A., Demaine A.G., A novel polymorphism in the 5′ flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with type 1 diabetes mellitus, J. Diabetes Complications, 2005, 19, 65–69 http://dx.doi.org/10.1016/j.jdiacomp.2004.07.00210.1016/j.jdiacomp.2004.07.002Search in Google Scholar PubMed
[12] Brosius F.C., Heilig C.W., Glucose transporters in diabetic nephropathy, Pediatr. Nephrol., 2005, 20, 447–451 http://dx.doi.org/10.1007/s00467-004-1748-x10.1007/s00467-004-1748-xSearch in Google Scholar PubMed
[13] Nannipieri M., Penno G., Pucci L., Colhoun H., Motti C., Bertacca A., et al., Pronatriodilatin gene polymorphisms, microvascular permeability, and diabetic nephropathy in type 1 diabetes mellitus, J. Am. Soc. Nephrol., 1999, 10, 1530–1541 10.1681/ASN.V1071530Search in Google Scholar PubMed
[14] Watarai A., Nakashima E., Hamada Y., Watanabe G., Naruse K., Miwa K., et al., Aldose reductase gene is associated with diabetic macroangiopathy in Japanese type 2 diabetic patients, Diabet. Med., 2006, 23, 894–899 http://dx.doi.org/10.1111/j.1464-5491.2006.01946.x10.1111/j.1464-5491.2006.01946.xSearch in Google Scholar PubMed PubMed Central
[15] Romzova M., Hohenadel D., Kolostova K., Pinterova D., Fojtikova M., Ruzickova S., et al., NFkappaB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complications, Hum. Immunol., 2006, 67, 706–713 http://dx.doi.org/10.1016/j.humimm.2006.05.00610.1016/j.humimm.2006.05.006Search in Google Scholar PubMed
[16] Zanchi A., Moczulski D.K., Hanna L.S., Wantman M., Warram J.H., Krolewski A.S., Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism, Kidney. Int., 2000, 57, 405–413 http://dx.doi.org/10.1046/j.1523-1755.2000.00860.x10.1046/j.1523-1755.2000.00860.xSearch in Google Scholar PubMed
[17] Liao L., Lim M.C., Chan S.W., Zhao J.J., Lee KO., Nitric oxide synthase gene polymorphisms and nephropathy in Asians with type 2 diabetes, J. Diabetes Complications, 2006, 20, 71–75 http://dx.doi.org/10.1016/j.jdiacomp.2005.10.00610.1016/j.jdiacomp.2005.10.006Search in Google Scholar PubMed
[18] Borg H., Arnqvist H.J., Björk E., Bolinder J., Eriksson J.W., Nyström L., et al, Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15–34 yrs) in the Diabetes Incidence Study in Sweden (DISS), Diabetologia, 2003, 46, 173–181, Erratum in, Diabetologia, 2004, 47, 154 http://dx.doi.org/10.1007/s00125-002-1021-410.1007/s00125-002-1021-4Search in Google Scholar PubMed
[19] Guldiken B., Sipahi T., Guldiken S., Ustundag S., Budak M., Turgut N., et al., Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in Turkish patients with ischemic stroke, Mol. Biol. Rep, 2009, 36, 1539–1543 http://dx.doi.org/10.1007/s11033-008-9348-710.1007/s11033-008-9348-7Search in Google Scholar PubMed
[20] Thameem F., Puppala S., Arar N.H., Stern M.P., Blangero J., Duggirala R., et al., Endothelial nitric oxide synthase (eNOS) gene polymorphisms and their association with type 2 diabetes-related traits in Mexican Americans, Diab. Vasc. Dis. Res., 2008, 5, 109–113 http://dx.doi.org/10.3132/dvdr.2008.01810.3132/dvdr.2008.018Search in Google Scholar PubMed PubMed Central
[21] Fatini C., Sofi F., Sticchi E., Bolli P., Sestini I., Falciani M., et al., eNOS G894T polymorphism as a mild predisposing factor for abdominal aortic aneurysma, J. Vasc. Surg., 2005, 42, 415–419 http://dx.doi.org/10.1016/j.jvs.2005.05.04410.1016/j.jvs.2005.05.044Search in Google Scholar PubMed
[22] Giusti B., Gori A.M., Marcucci R., Sestini I., Saracini C., Sticchi E., et al., Role of C677T and A1298C MTHFR, A2756G MTR and -786 T/C eNOS gene polymorphisms in atrial fibrillation susceptibility, PLoS One, 2007, 2, e495 http://dx.doi.org/10.1371/journal.pone.000049510.1371/journal.pone.0000495Search in Google Scholar PubMed PubMed Central
[23] Freitas-Silva M., Pereira D., Coelho C., Bicho M., Lopes C., Medeiros R., Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women, Cancer. Genet. Cytogenet., 2004, 155, 42–46 http://dx.doi.org/10.1016/j.cancergencyto.2004.03.02010.1016/j.cancergencyto.2004.03.020Search in Google Scholar PubMed
[24] Hodgkinson A.D., Millward B.V., Demaine A.G., Polymorphism of the glucose transporter (GLUT1) gene is associated with diabetic nephropathy, Kidney Int., 2001, 59, 985–989 http://dx.doi.org/10.1046/j.1523-1755.2001.059003985.x10.1046/j.1523-1755.2001.059003985.xSearch in Google Scholar PubMed
[25] Schmidt S., Ritz E., Genetic determinants of diabetic renal disease and their impact on therapeutic interventions, Kidney Int. Suppl., 1997, 63, S27–31 Search in Google Scholar
[26] Tarnow L., Gluud C., Parving H.H., Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene, Nephrol. Dial. Transplant., 1998, 13, 1125–1130 http://dx.doi.org/10.1093/ndt/13.5.112510.1093/ndt/13.5.1125Search in Google Scholar PubMed
[27] Hadjadj S., Tarnow L., Forsblom C., Kazeem G., Michel Marre, Groop P-H., et al., FD Study Group, Hager-Vionnet N, for the EURAGEDIC Study Group, Association between Angiotensin-Converting Enzyme Gene Polymorphisms and Diabetic Nephropathy, Case-Control, Haplotype, and Family-Based Study in Three European Populations, J. Am. Soc. Nephrol., 2007, 18, 1284–1291 http://dx.doi.org/10.1681/ASN.200610110210.1681/ASN.2006101102Search in Google Scholar PubMed
[28] Movva S., Alluri R.V., Komandur S., Vattam K., Eppa K., Mukkavali K.K., et al., Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians, J Diabetes Complications, 2007, 21, 237–241 http://dx.doi.org/10.1016/j.jdiacomp.2006.07.00110.1016/j.jdiacomp.2006.07.001Search in Google Scholar PubMed
[29] Boström K.B., Hedner J., Melander O., Grote L., Gullberg B., Råstam L., et al., Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension, J. Hypertens., 2007, 25, 779–783 http://dx.doi.org/10.1097/HJH.0b013e328017f6d510.1097/HJH.0b013e328017f6d5Search in Google Scholar PubMed
[30] Parving H-H., de Zeeuw D., Cooper M.E., Remuzzi G., Liu N., Lunceford J., et al., ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy, J. Am. Soc. Nephrol., 2008, 19, 771–779 http://dx.doi.org/10.1681/ASN.200705058210.1681/ASN.2007050582Search in Google Scholar PubMed PubMed Central
[31] Ruggenenti P., Bettinaglio P., Pinares F., Remuzzi G., Angiotensin Converting Enzyme Insertion/Deletion Polymorphism and Renoprotection in Diabetic and Nondiabetic Nephropathies, Clin. J. Am. Soc. Nephrol., 2008, 3, 1511–1525 http://dx.doi.org/10.2215/CJN.0414090710.2215/CJN.04140907Search in Google Scholar PubMed PubMed Central
[32] Ezzidi I., Mtiraoui N., Kacem M., Chaieb M., Mahjoub T., Almawi W.Y., Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy, Diabetes Metab. Res. Rev., 2009, 25, 717–724 http://dx.doi.org/10.1002/dmrr.100610.1002/dmrr.1006Search in Google Scholar PubMed
[33] Tarnow L., Grarup N., Hansen T., Parving H-H., Pedersen O., Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients, Nephrol. Dial. Transplant, 2001, 16, 1653–1656 http://dx.doi.org/10.1093/ndt/16.8.165310.1093/ndt/16.8.1653Search in Google Scholar PubMed
[34] Noiri E., Satoh H., Taguchi J., Brodsky S.V., Nakao A., Ogawa Y., et al., Association of eNOS Glu298Asp Polymorphism With End-Stage Renal Disease, Hypertension, 2002, 40, 535–540 http://dx.doi.org/10.1161/01.HYP.0000033974.57407.8210.1161/01.HYP.0000033974.57407.82Search in Google Scholar
[35] Nagase S., Suzuki H., Wang Y., Kikuchi S., Hirayama A., Ueda A., et al., Association of ecNOS gene polymorphisms with end stage renal diseases, Mol. Cell. Biochem., 2003, 244, 113–118 http://dx.doi.org/10.1023/A:102247340527510.1023/A:1022473405275Search in Google Scholar
[36] Ahluwalia T.S., Ahuja M., Rai T.S., Kohli H.S., Sud K., Bhansali A., et al., Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians, Mol. Cell. Biochem., 2008, 314, 9–17 http://dx.doi.org/10.1007/s11010-008-9759-810.1007/s11010-008-9759-8Search in Google Scholar PubMed
[37] Klahr S., The role of nitric oxide in hypertension and renal disease progression, Nephrol. Dial. Transplant., 2001, 16, 60–62 http://dx.doi.org/10.1093/ndt/16.6.A6010.1093/ndt/16.6.A60Search in Google Scholar
[38] Ezzidi I., Mtiraoui N., Mohamed M.B., Mahjoub T., Kacem M., Almawi W.Y., Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy, Clin. Endocrinol. (Oxf), 2008, 68, 542–546 http://dx.doi.org/10.1111/j.1365-2265.2007.03089.x10.1111/j.1365-2265.2007.03089.xSearch in Google Scholar PubMed
[39] Awata T., Neda T., Iizuka H., Kurihara S., Ohkubo T., Takata N., et al., Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes, Diabetes Care, 2004, 27, 2184–2190 http://dx.doi.org/10.2337/diacare.27.9.218410.2337/diacare.27.9.2184Search in Google Scholar PubMed
[40] Liu Y., Burdon K.P., Langefeld C.D., Beck S.R., Wagenknecht L.E., Rich S.S., et al., T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study, J. Am. Soc. Nephrol., 2005, 16, 1085–1090 http://dx.doi.org/10.1681/ASN.200410081710.1681/ASN.2004100817Search in Google Scholar PubMed
[41] Brenol C.V., Chies J.A., Brenol J.C., Xavier R.M., Role of endothelial nitric oxide synthase (eNOS) polymorphisms in cardiovascular disease and rheumatoid arthritis, Clin. Exp. Rheumatol., 2010, 28, 84 Search in Google Scholar
[42] Rossing P., Tarnow L., Nielsen F.S., Boelskifte S., Brenner B.M., Parving H-H., Short stature and diabetic nephropathy, BMJ., 1995, 310, 296–297 http://dx.doi.org/10.1136/bmj.310.6975.29610.1136/bmj.310.6975.296Search in Google Scholar PubMed PubMed Central
[43] Ciftçi C., Melil S., Cebi Y., Ersöz M., Cağatay P., Kiliçgedik M., et al., Association of endothelial nitric oxide synthase promoter region (T-786C) gene polymorphism with acute coronary syndrome and coronary heart disease, Lipids Health Dis., 2008, 25,7:5 http://dx.doi.org/10.1186/1476-511X-7-510.1186/1476-511X-7-5Search in Google Scholar PubMed PubMed Central
[44] Nurkalem Z., Tangurek B., Zencirci E., Alper A.T., Aksu H., Erer B., et al., Endothelial nitric oxide synthase gene (T-786C) polymorphism in patients with slow coronary flow, Coron. Artery Dis., 2008, 19, 85–88 http://dx.doi.org/10.1097/MCA.0b013e3282f5294010.1097/MCA.0b013e3282f52940Search in Google Scholar PubMed
[45] Colombo M.G., Paradossi U., Andreassi M.G., Botto N., Manfredi S., Masetti S., et al., Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease, Clin. Chem., 2003, 49, 389–395 http://dx.doi.org/10.1373/49.3.38910.1373/49.3.389Search in Google Scholar PubMed
[46] Hyndman M.E., Parsons H.G., Verma S., Bridge P.J., Edworthy S., Jones C., et al., The T-786—>C mutation in endothelial nitric oxide synthase is associated with hypertension, Hypertension, 2002, 39, 919–922 http://dx.doi.org/10.1161/01.HYP.0000013703.07316.7F10.1161/01.HYP.0000013703.07316.7FSearch in Google Scholar PubMed
[47] Sandrim V.C., de Syllos R.W., Lisboa H.R., Tres G.S., Tanus-Santos J.E., Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus, Atherosclerosis, 2006, 189, 241–246 http://dx.doi.org/10.1016/j.atherosclerosis.2005.12.01110.1016/j.atherosclerosis.2005.12.011Search in Google Scholar PubMed
[48] Erbs S., Baither Y., Linke A., Adams V., Shu Y., Lenk K., et al., Promoter but not exon 7 polymorphism of endothelial nitric oxide synthase affects traininginduced correction of endothelial dysfunction, Arterioscler. Thromb Vasc. Biol., 2003, 23, 1814–1819 http://dx.doi.org/10.1161/01.ATV.0000090128.11465.1810.1161/01.ATV.0000090128.11465.18Search in Google Scholar PubMed
[49] Kaplan N.M., The deadly quartet, Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension, Arch. Intern. Med., 1989, 149, 1514–1520 http://dx.doi.org/10.1001/archinte.1989.0039007005400510.1001/archinte.1989.00390070054005Search in Google Scholar
[50] Groop L.C., Insulin resistance, the fundamental trigger of type 2 diabetes, Diabetes Obes. Metab., 1999, 1, S1–7 http://dx.doi.org/10.1046/j.1463-1326.1999.0010s1001.x10.1046/j.1463-1326.1999.0010s1001.xSearch in Google Scholar PubMed
[51] Imamura A., Takahashi R., Murakami R., Kataoka H., Cheng X.W., Numaguchi Y., et al., The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects, the significance of plasma adiponectin levels, Eur. J. Endocrinol., 2008, 158, 189–195 http://dx.doi.org/10.1530/EJE-07-063210.1530/EJE-07-0632Search in Google Scholar PubMed
[52] Ohtoshi K., Yamasaki Y., Gorogawa S., Hayaishi-Okano R., Node K., Matsuhisa M, et al., Association of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance, Diabetologia, 2002, 45, 1594–1601 http://dx.doi.org/10.1007/s00125-002-0922-610.1007/s00125-002-0922-6Search in Google Scholar PubMed
[53] González-Sánches J.L., Martínez-Larrad M.T., Sáez M.E., Zabena C., Martínez-Calatrava M.J., Serrano-Rios M., Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome, Clin Chem., 2007, 53, 91–97 http://dx.doi.org/10.1373/clinchem.2006.07517610.1373/clinchem.2006.075176Search in Google Scholar PubMed
[54] Monti L.D., Barlassina C., Citterio L., Galluccio E., Berzuini C., Setola E., et al., Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome, Diabetes, 2003, 52, 1270–1275 http://dx.doi.org/10.2337/diabetes.52.5.127010.2337/diabetes.52.5.1270Search in Google Scholar
[55] Bedir A., Arik N., Adam B., Kilinç K., Gümüş T., Güner E., Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension, Am J Hypertens, 1999, 12, 1038–1043 http://dx.doi.org/10.1016/S0895-7061(99)00096-510.1016/S0895-7061(99)00096-5Search in Google Scholar
[56] Bawazier L.A., Sja’bani M., Haryana S.M., Soesatyo M.H., Sadewa A.H., Relationship of angiotensin converting enzyme gene polymorphism and hypertension in Yogyakarta, Indonesia, Acta Med. Indones., 2010, 42, 192–198 Search in Google Scholar
[57] Akra-Ismail M., Makki R.F., Chmaisse H.N., Kazma A., Zgheib N.K., Association between angiotensinconverting enzyme insertion/deletion genetic polymorphism and hypertension in a sample of Lebanese patients, Genet. Test Mol. Biomarkers 2010, 14, 787–792 http://dx.doi.org/10.1089/gtmb.2010.009610.1089/gtmb.2010.0096Search in Google Scholar
[58] Araz M., Aynacioglu S., Aktaran S., Alasehirli B., Okan V., Association between polymorphism of the angiotensin I converting enzyme gene and hypertension in Turkish type II diabetic patients, Acta Medica (Hradec Kralove), 2001, 44, 29–32 10.14712/18059694.2019.83Search in Google Scholar
[59] Fradin S., Goulet-Salmon B., Chantepie M., Grandhomme F., Morello R., Jauzac P., et al., Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients, Diabetes Metab., 2002, 28, 27–32 Search in Google Scholar
[60] Hadjadj S., Gallois Y., Alhenc-Gelas F., Chatellier G., Marre M., Genes N., et al., Diabhycar Study Group, Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients, Diabet. Med., 2003, 20, 677–682 http://dx.doi.org/10.1046/j.1464-5491.2003.01024.x10.1046/j.1464-5491.2003.01024.xSearch in Google Scholar
[61] Gutiérrez C., Vendrell J., Pastor R., Llor C., Aguilar C., Broch M., et al., Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus, Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population, Metabolism, 1997, 46, 976–980 http://dx.doi.org/10.1016/S0026-0495(97)90090-110.1016/S0026-0495(97)90090-1Search in Google Scholar
[62] Schmidt S., Schöne N., Ritz E., Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group, Kidney In., 1995, 47, 1176–1181 10.1038/ki.1995.167Search in Google Scholar
[63] Fujisawa T., Ikegami H., Kawaguchi Y., Hamada Y., Ueda H., Shintani M., et al., Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy, Diabetologia, 1998, 41, 47–53 http://dx.doi.org/10.1007/s00125005086510.1007/s001250050865Search in Google Scholar
[64] Gohda T., Makita Y., Shike T., Kobayashi M., Funabiki K., Haneda M., et al., Association of the DD genotype and development of Japanese type 2 diabetic nephropathy, Clin. Nephrol., 2001, 56, 475–480 Search in Google Scholar
[65] Ha S.K., Park HC., Park H.S., Kang B.S., Lee T.H., Hwang H.J., et al., ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients, effect of ACE gene DD on the progression of diabetic nephropathy, Am. J. Kidney. Dis., 2003, 41, 943–949 http://dx.doi.org/10.1016/S0272-6386(03)00191-410.1016/S0272-6386(03)00191-4Search in Google Scholar
[66] Jeffers B.W., Estacio R.O., Raynolds M.V., Schrier R.W., Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy, Kidney Int., 1997, 52, 473–477 http://dx.doi.org/10.1038/ki.1997.35510.1038/ki.1997.355Search in Google Scholar PubMed
[67] Ohno T., Kawazu S., Tomono S., Association analyses of the polymorphisms of angiotensinconverting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics, Metabolism, 1996, 45, 218–222 http://dx.doi.org/10.1016/S0026-0495(96)90057-810.1016/S0026-0495(96)90057-8Search in Google Scholar
[68] Movva S., Alluri R.V., Komandur S., Vattam K, Eppa K., Mukkavali K.K., et al., Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians, J. Diabetes Complications, 2007, 21, 237–241 http://dx.doi.org/10.1016/j.jdiacomp.2006.07.00110.1016/j.jdiacomp.2006.07.001Search in Google Scholar
[69] Tomino Y., Makita Y., Shike T., Gohda T., Haneda M., Kikkawa R., et al., Relationship between polymorphism in the angiotensinogen, angiotensinconverting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients, Nephron, 1999, 82, 139–144 http://dx.doi.org/10.1159/00004539010.1159/000045390Search in Google Scholar
[70] Wang X.L., Wang J., Endothelial nitric oxide synthase gene sequence variations and vascular disease, Mol. Genet. Metab., 2000, 70, 241–251 http://dx.doi.org/10.1006/mgme.2000.303310.1006/mgme.2000.3033Search in Google Scholar
[71] Panagiotopoulos S., Smith T.J., Aldred G.P., Baker E.J., Jacklin C.J., Jerums G., Angiotensinconverting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate, J. Diabetes Complications, 1995, 9, 272–276 http://dx.doi.org/10.1016/1056-8727(95)80020-F10.1016/1056-8727(95)80020-FSearch in Google Scholar
[72] Taniwaki H., Ishimura E., Matsumoto N., Emoto M., Inaba M., Nishizawa Y., Relations between ACE gene and eNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy, Diabetes Care, 2001, 24, 1653–1660 http://dx.doi.org/10.2337/diacare.24.9.165310.2337/diacare.24.9.1653Search in Google Scholar PubMed
[73] Liao L., Lei M.X., Chen H.L., Angiotensin converting enzyme gene polymorphism and type 2 diabetic nephropathy, Hunan Yi Ke Da Xue Xue Bao, 2003, 28, 553–556 (in Chinese) Search in Google Scholar
[74] Shin Shin Y., Baek S.H., Chang K.Y., Park C.W., Yang C.W., Jin D.C., et al., Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy, Diabetes Res. Clin. Pract., 2004, 65, 257–265 http://dx.doi.org/10.1016/j.diabres.2004.01.01010.1016/j.diabres.2004.01.010Search in Google Scholar PubMed
[75] Liu Z.H., Guan T.J., Chen Z.H., Li LS., Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus, Kidney Int., 1999, 55, 1843–1848 http://dx.doi.org/10.1046/j.1523-1755.1999.00449.x10.1046/j.1523-1755.1999.00449.xSearch in Google Scholar PubMed
[76] Hodgkinson A.D., Millward B.A., Demaine A.G., Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy, Kidney Int., 2001, 59, 985–989 http://dx.doi.org/10.1046/j.1523-1755.2001.059003985.x10.1046/j.1523-1755.2001.059003985.xSearch in Google Scholar PubMed
[77] Ng D.P., Canani L., Araki S., Smiles A., Moczulski D., Warram J.H., et al., Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes, Diabetes, 2002, 51, 2264–2269 http://dx.doi.org/10.2337/diabetes.51.7.226410.2337/diabetes.51.7.2264Search in Google Scholar PubMed
[78] Gutierrez C., Vendrell J., Pastor R., Broch M., Aguilar C., Llor C., et al., GLUT1 gene polymorphism in non-insulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population, Diabetes Res. Clin. Pract., 1998, 41, 113–120 http://dx.doi.org/10.1016/S0168-8227(98)00050-310.1016/S0168-8227(98)00050-3Search in Google Scholar
[79] Tarnow L., Grarup N., Hansen T., Parving H.H., Pedersen O., Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients, Nephrol. Dial. Transplant. 2001, 16, 1653–1656 http://dx.doi.org/10.1093/ndt/16.8.165310.1093/ndt/16.8.1653Search in Google Scholar PubMed
[80] Noiri E., Satoh H., Taguchi J., Brodsky S.V., Nakao A., Ogawa Y., et al., Association of eNOS Glu298Asp polymorphism with end-stage renal disease, Hypertension, 2002, 40, 535–540 http://dx.doi.org/10.1161/01.HYP.0000033974.57407.8210.1161/01.HYP.0000033974.57407.82Search in Google Scholar
[81] Nagase S., Suzuki H., Wang Y., Kikuchi S., Hirayama A., Ueda A., et al., Association of ecNOS gene polymorphisms with end stage renal diseases, Mol. Cell. Biochem., 2003, 244, 113–118 http://dx.doi.org/10.1023/A:102247340527510.1023/A:1022473405275Search in Google Scholar
[82] Chen Y., Huang H., Zhou J., Doumatey A., Lashley K., Chen G., et al., Polymorphism of the endothelial nitric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans, Mol. Vis., 2007, 13, 2142–2147 Search in Google Scholar
[83] Thameem F., Puppala S., Arar N.H., Stern M.P., Blangero J., Duggirala R., et al., Endothelial nitric oxide synthase (eNOS) gene polymorphisms and their association with type 2 diabetes-related traits in Mexican Americans, Diab. Vasc. Dis. Res., 2008, 5, 109–113 http://dx.doi.org/10.3132/dvdr.2008.01810.3132/dvdr.2008.018Search in Google Scholar PubMed PubMed Central
© 2012 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.